Cabot Medical
This article was originally published in The Gray Sheet
Executive Summary
Receives clearance from FDA to market the Seitzinger Tripolar cutting forceps, the firm announces Aug. 9. Designed "to replace more expensive stapling devices" in procedures such as hysterectomies, gall bladder removal, appendectomies and other gynecological and general surgical procedures, the device "enables the surgeon to cauterize tissue to reduce or eliminate bleeding, while activating a cutting knife allowing the tissue to be transected in a one-handed operation." The firm maintains that "in addition to the savings from not using any staples, the operating time can be reduced by as much as one third" with use of the device